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Abstract
Enhancing chondrogenic and osteogenic differentiation is of paramount importance in providing effective regenerative
therapies and improving the rate of fracture healing. This study investigated the potential of non-thermal atmospheric
dielectric barrier discharge plasma (NT-plasma) to enhance chondrocyte and osteoblast proliferation and differentiation.
Although the exact mechanism by which NT-plasma interacts with cells is undefined, it is known that during treatment the
atmosphere is ionized generating extracellular reactive oxygen and nitrogen species (ROS and RNS) and an electric field.
Appropriate NT-plasma conditions were determined using lactate-dehydrogenase release, flow cytometric live/dead assay,
flow cytometric cell cycle analysis, and Western blots to evaluate DNA damage and mitochondrial integrity. We observed
that specific NT-plasma conditions were required to prevent cell death, and that loss of pre-osteoblastic cell viability was
dependent on intracellular ROS and RNS production. To further investigate the involvement of intracellular ROS, fluorescent
intracellular dyes Mitosox (superoxide) and dihydrorhodamine (peroxide) were used to assess onset and duration after NT-
plasma treatment. Both intracellular superoxide and peroxide were found to increase immediately post NT-plasma
treatment. These increases were sustained for one hour but returned to control levels by 24 hr. Using the same treatment
conditions, osteogenic differentiation by NT-plasma was assessed and compared to peroxide or osteogenic media
containing b-glycerolphosphate. Although both NT-plasma and peroxide induced differentiation-specific gene expression,
neither was as effective as the osteogenic media. However, treatment of cells with NT-plasma after 24 hr in osteogenic or
chondrogenic media significantly enhanced differentiation as compared to differentiation media alone. The results of this
study show that NT-plasma can selectively initiate and amplify ROS signaling to enhance differentiation, and suggest this
technology could be used to enhance bone fusion and improve healing after skeletal injury.
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Introduction
The goal of this investigation was to examine the effect of non-
thermal (NT)-plasma on skeletal cell differentiation. Medical use of
plasma technology is most commonly associated with thermal
plasmas, such as the plasma knife used in surgery to cut and
simultaneously cauterize vessels as a result of the high temperature
generated by plasma [1]. Advancements in atmospheric pressure
plasma systems led to the development of a novel NT dielectric
barrier discharge plasma with a discharge sufficiently uniform and
cold to safely apply to living cells and tissues [2–6]. The NT-
plasma discharge is generated by applying a high voltage, time-
varying waveform between a dielectric covered electrode and the
biological target [7,8]. To prevent high temperature build-up and
transition to arc, high voltage current is alternated between the
two electrodes, one of which is covered with a dielectric. Within
the NT-plasma discharge, the molecules present in air (O2, N2,
H2O, CO2, etc) are ionized resulting in the direct formation of
numerous reactive oxygen species (ROS) and reactive nitrogen
species (RNS) [8–10].
Most biomedical studies on the effect of NT-plasma have
focused on the bacteriostatic and bactericidal properties of this
new technology [11–13]. Recently, it was reported that NT-
plasma exposure promoted endothelial cell proliferation, which
was abrogated by fibroblast growth factor (FGF)-2 neutralizing
antibody [5]. Proliferation and FGF-2 release were blocked by N-
acetyl-cysteine (NAC), which prevented changes in intracellular
redox. Mechanistically, these studies directly link NT-plasma
effects to ROS or RNS generation.
ROS and RNS are known to directly activate multiple proteins
involved in signaling pathways that regulate cell function. ROS-
responsive MAP kinases are known to control a wide range of
cellular processes including: cellular differentiation, cell cycle
control, cytokine and growth factor signaling, survival, hypertro-
phy and/or apoptosis [14–17]. For example, the Map5kinase
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Apoptosis signal-regulating kinase 1 (ASK1), is particularly
sensitive to ROS as its activity is tightly regulated by four ROS
sensitive proteins thioredoxin, glutaredoxin, Akt and 14-3-3 [17–
21]. ROS activated ASK1 phosphorylates and activates both p38
and jnk kinases, which play key roles in cellular differentiation
[22,23] as well as the regulation of apoptosis [24]. Activation of
ASK1, p38 and/or jnk promotes the differentiation of several cell
lineages including chondrocytes [25–27], osteoblasts, neuronal
[28], myoblasts [29] and keratinocytes [14,23,27].
In the case of mesenchymal cell differentiation into osteoblast
lineages there is precedence for ROS stimulation to both direct
and enhance this process [30–32]. Similarly, enhanced chondro-
genesis has also been associated with ROS stimulation [27] and
the occurrence of oxidative spikes as a driving force for transitional
stages throughout developmental and regenerative processes is a
commonly observed phenomena. The possibility of using NT-
plasma technology to artificially trigger these transitions and direct
these processes is intriguing. Herein, we show that specific
exposure conditions to NT-plasma promote intracellular ROS
production and skeletal cell differentiation.
Materials and Methods
Cell Culture
The pre-osteocytic cell line MLO-A5 was obtained from Dr.
Linda Bonewald and cultured using the method described
previously [33]. To induce maturation for qRT-PCR experiments
MLO-A5, cells were placed in osteogenic differentiation media
(Dulbecco’s Modified Eagle’s Medium (DMEM) (Cellgro, Fisher
Scientific, USA) with 10% Fetal Bovine Serum (FBS) (Invitrogen,
Life Science Technologies, USA), and supplemented with 100
units/ml penicillin, 100 mg/ml streptomycin (Cellgro, Fisher
Scientific, USA), 0.5 mM beta glycero-phosphate and 100 mg/
ml ascorbic acid (Sigma-Aldrich, St. Louis, MO) and incubated in
5% CO2 at 37uC with media changes every 2 days. N1511 mouse
chondrocytes were obtained from Dr. Motomi Enomoto-Iwamoto.
The cells were maintained in culture using the method described
previously [34,35]. Briefly, the cells were plated at a concentration
of 50,000 cells/ml in/2MEM containing 10% FBS, 0.2% L-
glutamine, and penicillin/streptomycin. To induce maturation,
after 24 h, the adherent cells were treated with 200 ng/ml
recombinant BMP2 (Alpha Diagnostic Intl., San Antonio, TX).
Assessment of the maturation was performed at day 5 by
measuring alkaline phosphatase activity and the expression of
chondrogenic markers.
Power Measurement for Calibration of Plasma Device
Tektronix DPO4104B (1 GHz bandwidth, 5 GS/sec) digital
oscilloscope with Tektronix P6015A high voltage divider (1000:1)
and Ion Physics Corp CM-10-L current probe (1 V/1 A, 5 kA
max) was used to record voltage and current waves at maximum
sampling rate. Instant values for both were multiplied and
resulting instant power was then integrated over the entire cycle.
Ten measurements were taken for statistics analysis.
Non-Thermal Plasma Treatment
NT-plasma was generated by applying alternating polarity
pulsed voltage of 20 kV magnitude (peak to peak), a 10 ms pulse
width, at a frequency between 50 to 3500 Hertz (Hz), with a rise
time of 5 V/ns between the quartz-insulated high voltage
electrode and the sample undergoing treatment 2 mm from the
electrode. General electrical schematics and description of the
power supply (Plasma Power, LLC, Philadelphia USA) were as
reported by the authors [4]. A 32 mm (6-well plate) electrode was
used, which was composed of an inner core of copper surrounded
by an outer insulating shell of acrylic, and a 0.5 mm quartz disc
plasma-generating surface covered with a 0.01inch sheet of
polyether ether ketone. Just before treatment, culture media was
removed by pipet from the dish and replaced immediately
following treatment.
Cell Viability and Cell Cycle Analysis
Cell viability was measured by live/dead flow cytometry in cells
stained with propidium iodide (PI; Sigma), an indicator of cell
death. PI was added immediately before analysis on the
MACSQuant VYB flow cytometer (Miltenyi Biotec, Auburn,
CA). The number of PI stained cells was counted and the data was
analyzed with MACSQuant software (Miltenyi Biotec, Auburn,
CA).
Lactate dehydrogenase (LDH) (Cayman Chemical, Ann Arbor,
MI) assay was performed at 24 hr as per manufacturer’s
instructions, and the % cytotoxicity (LDH release) was calculated
from the standard curve and TritonX-100 positive control.
Intensity measurements were performed using a Tecan Infinite
1000 plate reader (Tecan, Research Triangle, NC). H2O2
(100 mM) (Life Technologies, Grand Island, NY) or 1-oxyl-
2,2,6,6-tetramethyl-4-hydroxypiperidine (TEMPOL; 6 mM) (Sig-
ma, St. Louis, MO) was added to the medium for one hour before
NT-plasma treatment. The media was replaced after 3 hr without
H2O2 or TEMPOL.
To determine cell cycle kinetics, 24 hr after NT-plasma
treatment cells were prepared for flow cytometric cell cycle
analysis on the MACSQuant VYB (Miltenyi Biotec, Auburn, CA),
following the Miltenyi cell cycle analysis protocol. Briefly, cells
were collected in sample buffer (Ca+2 and Mg+2 free PBS, with
1 g/L glucose), washed and placed in 70% ethanol overnight at
4uC. After re-suspension in sample buffer, the propidium iodide
(PI (1 ug/ml); Sigma, St. Louis, MO) was added and the stained
cells were analyzed with MACSQuant software (Miltenyi Biotec,
Auburn, CA). This procedure was repeated in quadruplicate on 3
separate days.
Western Blot Analysis for DNA and Mitochondrial
Damage
Protein from NT-plasma treated cells was collected 24 hr after
treatment. Cells were isolated with MPERH, 5 M NaCl, complete
protease inhibitor cocktail, DTT, 100 mM NaF, and 100 mM
Na3VO4 and quantified using the Bradford assay (Pierce
Biotechnology Thermol Scientific, Rockford IL). Protein (40 mg)
was then loaded onto 10% Tris polyacrylamide gels. Samples were
transferred to PVDF membranes and subsequently blocked with
ECL Blocking agent (RPN 2125, GE Health Life Sciences,
Cleveland, OH) (2.0% TBS-T +2.0 g dried milk). Blots were
treated overnight with antibodies to either H2Ax (Millipore,
Billerica, MA) or Cytochrome C (BD Biosciences, Franklin Lakes,
NJ) at a 1:500 dilution in 2% blocking reagent. The blots were
washed three times in TBST and species specific HRP conjugated
secondary antibodies (Santa Cruz Biotechnology, Dallas, TX)
were applied for 1 hr at room temperature. After three washes in
TBST, the membrane was detected with Western Bright
Quantum kit (Advansta, Menlo Park, CA) for 5 min at 25uC.
Photographs of the membranes were taken in a GE Image quant
LAS 4000 dark box with a GE Luminescent Image Analyzer LAS-
4000 (GE Health Life Sciences, Cleveland, OH) and digital images
were collected using the Image quant TL 1D gel analysis software
(GE Health Life Sciences, Cleveland,OH).
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ROS Measurements
Mitosox and dihydrorhodamine (DHR) dyes (Invitrogen,
Carlsbad, CA) were used to detect the presence of intracellular
superoxide anion and hydrogen peroxide, respectively. NT-plasma
or sham treatments were performed on MLO-A5 cells plated
overnight in 6 well plates and fluorescent intensity was measured
using a Tecan Infinite 1000 plate reader (Tecan, Research
Triangle, NC). Inhibitors (NAC, 200 mM and TEMPOL, 6 mM
(Sigma, St. Louis, MO) were added to the medium for one hour
before NT-plasma treatment and replaced 3 hr after with regular
media.
Real Time-PCR for Differentiation Markers and
Comparative Analyses
Confluent cells in 6 well dishes were either treated with
differentiation media (b-GP), H2O2 (100 mM) or treated with
1000 Hz NT-plasma for 10 sec and harvested after 24 hr.
Alternatively, confluent cells from 6 well dishes were placed in
differentiation media (MLO-A5 with b-GP or N1511 with BMP)
24 hr before NT-plasma or sham-plasma control treatment and
harvested after 24 hr or 56 hr. All harvested cells were washed
with DEPC water before total RNA was isolated using the
QiagenRNeasyH Mini kit (Qiagen, Valencia, CA). RNA yield was
determined spectrophotometrically and integrity confirmed by gel
electrophoresis. RNA was reverse-transcribed and then amplified
using the SuperscriptTM One-Step RT-PCR with Platinum TaqH
(Invitrogen, Carlsbad, CA) kit. PCR products were analyzed by
1.0% agarose gel electrophoresis. Template cDNA and gene
specific primers were added to Fast SYBR Green master mix
(Applied Biosystems, Carlsbad, CA) and mRNA expression was
quantified using the MyIQ Real-Time PCR System (BioRad,
Hercules, CA). The expression level of the housekeeping gene, b-
actin was used to normalize the data presented. Melting curves
were analyzed to verify the specificity of the RT-PCR reaction and
the absence of primer dimer formation. Each sample is analyzed in
duplicate and included a template-free control. All the primers
(Table 1) used were synthesized by Integrated DNA Technologies,
Inc. (Coralville, IN).
Statistical Analysis
Statistical analysis between groups was performed using a one-
way ANOVA for normality and student’s t-test for continuous
variables. A level of significance (a), or a p-value of less than 0.05,
with a 95% confidence interval was determined. Representative
data are presented as the mean6 SD of individual samples from 2
to 16 independent analyses, unless otherwise stated. In this work
‘‘n’’ indicates number of separate experimental trials, with repeats
varying from 3 to 8, or more. For normally distributed data,
differences between groups were determined by independent t-
tests. For non-parametric data, Mann Whitney U tests were used
to evaluate differences.
Results
Determining the Appropriate NT-Plasma Dose
To investigate the appropriate NT-plasma dose, MLO-A5
osteoblastic cells in 6 well plates were treated with NT-plasma for
10 sec at a voltage of 20 kV and pulse width of 10 ms), varying
only the frequency at either 50, 1000, or 3500 Hertz (Hz).
Controls included the NT-plasma electrode without power as a
sham treatment, and H2O2 (100 mM) as a positive control for
ROS. Cell death was determined 24 hr after NT-plasma
treatment using a fluorescent flow cytometric live/dead assay.
Less than 4% of the cells underwent cell death in response to NT-
plasma treatment, although the 50 Hz (p,0.05) and 3500 Hz
(p,0.05) treatments were significantly above control (Fig. 1A).
H2O2 induced a slightly higher 5.6% increase in cell death
(p,0.01). Results for the 3500 Hz treatment, were an under
estimate of cell damage, as large areas of the culture plate were
devoid of cells immediately after treatment (Fig. 1B). Due to cell
detachment this setting was not used in subsequent assays.
To further assess the 50 and 1000 Hz dose rates, MLO-A5 cell
cytotoxicity was measured using lactate dehydrogenase (LDH)
(Fig. 1C). At 24 h LDH release in response to 50 Hz was 5.1%
(not significant; ns) and 1000 Hz was 7.7% (p,0.01) above NT-
plasma sham control. Both treatments were less than H2O2, which
induced an 11.2% increase in cell death (p,0.01). To prevent
changes in intracellular oxidant levels, TEMPOL (6 mM) a
membrane permeable scavenger of both ROS and RNS, was
added 1 hr before NT-plasma or H2O2 treatment [36,37].
TEMPOL reduced the release of LDH in response to 1000 Hz
NT-plasma (ns) and significantly decreased LDH release in
response to H2O2 (p,0.01), indicating ROS/RNS are being
generated in response to NT-plasma and cause cell damage.
To determine whether NT-plasma treatment affected cell
proliferation (increased S phase) or caused DNA damage (blockage
in G2), flow cytometric analysis of cell cycle phase was determined
24 hours after treatment of MLO-A5 cells with 50 and 1000 Hz
NT-plasma or H2O2 (Fig. 1D). No significant differences were
observed in the G1, S or G2/M phase after any treatment,
indicating no increase in cell proliferation or blockage of the cell
cycle due to DNA damage.
Additionally, Western blot analysis was performed to assess
damage to DNA or mitochondrial membranes using antibodies to
the histone2A variant (H2AX) and cytoplasmic cytochrome c,
respectively (Fig. 1E). The 1000 Hz NT-plasma treatment dose
was achieved by varying the time to include 10 sec (4.08 Joules (J)/
Table 1. PCR primer information.
Primer Name Strand Primer Sequence
actin FWD gct aca gct cac cac cac a
actin REV 251658240tct cca ggg agg aag agg a
Osteocalcin FWD gac aaa gcc ttc atg tcc aag c
Osteocalcin REV aaa gcc gag ctg cca gag ttt g
BMP2 FWD aag aag ccg tgg agg aac tt
BMP2 REV ttc ccg gaa gat ctg gag tt
BSP FWD agg gag gca gtg act ctt ca
BSP REV aca ccc gag agt gtg gaa ag
Runx2 FWD gcc ggg aat gat gag aac ta
Runx2 REV gga ccg tcc act gtc act tt
Fgf2 FWD agc ggc tct act gca aga ac
Fgf2 REV gcc gtc cat ctt cct tca ta
ALK PHOS FWD tat gtc tgg aac cgc act ga
ALK PHOS REV cca gca aga aga agc ctt tg
Col X FWD cgt gtc tgc ttt tac tgt ca
Col X REV acc tgg tca ttt tct gtg ag
MMP-13 FWD atc ctg gcc acc ttc ttc tt
MMP-13 REV ttt ctc gga gcc tgt caa ct
OSTERIX FWD act ggc tag gtg gtg gtc ag
OSTERIX REV ggt agg gag ctg ggt taa gg
doi:10.1371/journal.pone.0082143.t001
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cm2), 30 sec (12.24 J/cm2) and 60 sec (24.48 J/cm2) dose. The
10 sec dose did not induce DNA or mitochondrial damage within
1 hr after treatment, but damage after both the 30 and 60 sec
treatments was observed.
Taken together the results show that NT-plasma treatment at
1000 Hz for 10 sec did not significantly reduce cell viability, alter
the cell cycle or cause DNA or mitochondrial damage in MLO-A5
cells. Based on these findings the 1000 Hz, 10 sec NT-plasma
treatment was chosen as the NT-plasma optimal treatment.
Production of Intracellular ROS in Response to NT-Plasma
To evaluate intracellular reactive species levels in response to
NT-plasma at 1000 Hz, 10 sec, mitochondrial superoxide anion
(O2
2.) and cytosolic/mitochondrial H2O2 levels were measured
using fluorescent indicators MitoSox and dihydrorhodamine
(DHR), respectively. Measurements were done immediately post-
treatment (POST-PL), at 1 hr and 24 hr after NT-plasma and
results were compared to sham controls (pre-plasma, PRE-PL).
Immediately post-treatment and at 1 hr, NT-plasma treated cells
showed significantly increased intracellular O2
2. (Fig. 2A) and
H2O2 generation (p,0.001) (Fig. 2B) as compared to PRE-PL.
Levels of both oxidants returned to PRE-PL levels by 24 hr. The
immediate increase in H2O2 may be due to ROS produced by
NT-plasma but the extended detection indicates ROS are being
actively produced in response to NT-plasma.
To confirm the production of ROS in response to NT-plasma
treatment, MLO-A5 cells were pretreated for 1 hr with either
NAC (200 mM), to maintain intracellular redox balance and
interfere with ROS production [38] or TEMPOL (6 mM), a
scavenger of ROS as well as RNS. After pre-incubation with the
inhibitor, the cells were subjected to NT-plasma treatment at
1000 Hz for 10 sec. NAC significantly inhibited the POST-PL
and 1 hr NT-Plasma increase in both O2
2. (Fig. 2A) and H2O2
(Fig. 2B). TEMPOL also significantly inhibited the POST-PL and
1 hr increase in O2
2. (Fig. 2C), and it inhibited the POST-PL
increase in H2O2 (Fig. 2D). To lesser extent TEMPOL inhibited
the 1 hr increase in H2O2 in response to NT-Plasma, and at 24 hr
H2O2 production was increased (p,0.01). One possible explana-
tion for the decreased effectiveness of TEMPOL after 1 hr and
24 hr after NT-plasma/TEMPOL treatment is that removal of
NO. prevents its reaction with O2
2. and the production of
peroxynitrite (ONOO-). Thus, by scavenging NO. TEMPOL
Figure 1. Direct effects of NT-plasma on cytotoxicty and cell proliferation. Osteoblast-like, MLO-A5 cells were treated with NT-plasma at
frequencies of 50, 1000 and 3500 Hz for 10 seconds. (A) Cell death measured by nuclear PI incorporation at 24 hr showed increased cell death in
response to frequency 50 Hz, 3500 Hz (p,0.01) and H2O2 (p,0.001) (n = 3). There was no significant cell death in response to frequency 1000 Hz. (B)
Cell detachment was observed at 3500 Hz as shown by toluidine staining of cells after NT-plasma treatment. (C) Cell viability after NT-plasma was
assessed by a lactate dehydrogenase (LDH) release assay. 1000 Hz and H2O2 both showed an increase in LDH release (p,0.01 and p,0.001). LDH
release was reduced in the presence of TEMPOL for both H2O2 (p,0.01) and NT-plasma treatments (ns, n = 3). (D) No difference in cell cycle profile
was observed between NT-plasma at 50 Hz or 1000 Hz as compared to sham control. (E) Western blots show no H2Ax or cytochrome c release in
cells treated at 1000 Hz for 10 s as compared to the 30 and 60 sec NT-plasma treatments. Statistical significance was determined by the Mann-
Whitney U test for non-parametric data; * or # (p,0.01) ** or ## (p,0.001.
doi:10.1371/journal.pone.0082143.g001
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allows H2O2 to be generated from O2
2., rather than ONOO-,
indicating some NO. is being generated although at significantly
lower amounts compared to H2O2.
NT-plasma Differentiation of Osteoblasts and
Chondrocytes in vitro
To determine if NT-plasma treatment influenced the differen-
tiation of MLO-A5 cells, alkaline phosphatase (ALKP), bone
morphogenetic protein 2 (BMP2), bone sialoprotein (BSP) and
fibroblast growth factor-2 (FGF-2) expression was evaluated by
qPCR (Fig. 3). We compared differentiation media containing b-
glycerophosphate (bGP) to either NT-plasma or H2O2 treatment;
used to evaluate the effects of redox. Both NT-plasma and H2O2
increased the expression of osteogenic genes above controls, which
were undifferentiated cells sham treated with NT-plasma (Fig. 3A).
ALKP expression was upregulated 3 (ns) and 11 (p,0.01) fold,
respectively, and BMP2 and BSP were increased 5 fold by 24 hr
(p,0.05). However, compared to the 14–23 fold increases induced
by bGP alone (p,0.01), these changes were relatively small. FGF-
2 expression, which is increased in endothelial cells in response to
NT-plasma [5], was not affected in MLO-A5 cells by NT-plasma,
H2O2 or bGP. These results indicate NT-plasma does not
significantly promote osteoblast differentiation when compared
to bGP, although it induces some differentiation specific protein
expression.
As NT-plasma treatment evoked only a weak induction of
osteogenic gene expression, a potential synergism between bGP
and NT-plasma was investigated. NT-plasma treatment applied
24 hr after incubation in bGP, induced a 2–7 fold increase in the
expression levels of osteogenic markers BMP2 and ALKP above
bGP alone (p,0.05) (Fig. 3B). The expression of osterix (ostrx), a
key transcription factor for osteogenesis, was increased 15 fold
(p,0.01). At 56 hr after NT-plasma treatment, the late osteoblast
markers, BSP and osteocalcin (OSTCN) were increased 17–24
fold above bGP-treated control (p,0.05).
To determine if the differentiation effect of NT-plasma was
osteoblast specific, the N1511 chondrocyte cell line was subjected
to the same NT-plasma treatment in the presence of BMP2
(200 ng/ml), a known inducer of chondrocyte differentiation [34].
24 hr after treatment, chondrocyte differentiation markers Runx2,
ALKP were increased 3–6-fold above BMP-treated controls
(p,0.05) (Fig. 3C). By 56 hr, collagen type X (Col X) and another
late marker, matrix metalloprotease 13 (MMP13) were both
increased 20 (p,0.01) and 4-fold (p,0.05), respectively above
BMP-treated control.
We conclude from these studies that NT-plasma alone was not
sufficient to initiate significant changes in cell differentiation.
Figure 2. Direct effects of NT-plasma on intracellular ROS production. (A and B) Intracellular O2
2. and H2O2 levels were measured using
fluorescent indicators MitoSox (n = 3) and dihydrorhodamine (DHR), (n = 3) respectively. Immediately post-treatment (POST-PL) and at 1 hr, 1000 Hz
NT-plasma treated cells generated significantly increased amounts of O2
2. and H2O2 (p,0.001) as compared to sham control or pre-treatment levels
(PRE-PL). Amounts of both ROS were decreased by 24 hr. NAC and TEMPOL quenched the ROS increase POST-PL and at 1 hr (p,0.01–0.001).
However, H2O2 levels in the TEMPOL (p,0.01) inhibitor group were significantly increased above control at 24 hr, presumably due to removal of
baseline NO. The results are expressed as the mean 6 standard deviation. Statistical significance was determined by the Mann-Whitney U test for
non-parametric data; * or # (p,0.01) ** or ## (p,0.001.
doi:10.1371/journal.pone.0082143.g002
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Figure 3. NT-plasma induced osteogenic differentiation using qPCR markers. (A) Fold increases in the expression of alkaline phosphatase
(ALKP), bone morphogenetic protein 2 (BMP2), bone sialoprotein (BSP) and fibroblast growth factor-2 (FGF-2) in response to NT-plasma treatment,
H2O2 or b-glycerol phosphate (bGP) normalized to sham treated control cells after 24 hr. ALKP was upregulated 3- (NS) and 11-fold (p,0.01),
respectively, and BMP2 and BSP were increased 5 fold (p,0.05). bGP increased expression 14–23 fold (p,0.01). FGF-2 expression was not affected by
NT-plasma, H2O2 or bGP. (B) After a 24 hr incubation in bGP NT-plasma was applied. 24 hr later there was a 2–7 fold increase in the induction of
BMP2, ALKP (p,0.05) and Osterix was increased 15 fold (p,0.01) compared to bGP treatment alone. At 56 hr, BSP and osteocalcin (OSTCN) were
increased 17–24 fold above bGP-treated control (p,0.05). The results are expressed as the mean 6 standard deviation (n = 2). Statistical significance
was determined by the Wilcoxin Mann-Whitney test for non-parametric data; * (p,0.05), ** (p,0.01).
doi:10.1371/journal.pone.0082143.g003
NT-Plasma Enhances Skeletal Cell Growth
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However, once differentiation had been initiated, NT-plasma
enhanced osteogenesis and chondrogenesis at both early and late
time points.
Discussion
This study investigated the potential of NT-plasma to enhance
both chondrocyte and osteoblast differentiation. Initially, we
determined the specific NT-plasma condition required to maintain
cell viability and showed both an immediate and long-term
increase in intracellular ROS and RNS in response to NT-plasma.
Furthermore, we demonstrate that NT-plasma enhanced the
expression of differentiation specific genes by MLO-A5 in media
without differentiation factors and in differentiation media, In
media alone, the levels of expression were equal to those induced
by H2O2, but not as effective as differentiation medium. However,
when NT-plasma was applied 24 hr after the cells were placed in
differentiation media a synergistic enhancement of chondrogenic
and osteogenic differentiation was observed.
The NT-plasma generated ROS and RNS at the cell/
environment interface initiates an immediate intracellular oxida-
tive response (Fig. 2). It is interesting to speculate that this reaction
may mimic naturally occurring ROS-associated cell signaling
known to be associated with stem cell differentiation, cell fate
decisions and regeneration. Within the stem cell pool, quiescence
and pluripotency is maintained by the repression of ROS
generation [39,40]. As such, mouse and human embryonic stem
cells have immature mitochondria, reduced expression of
OXPHOS enzymes, low metabolic activity, low oxygen consump-
tion, decreased levels of ATP production [41], express modest
levels of antioxidant enzymes [40] and have a high glycolytic flux
[41]. In vivo, embryonic stem cells are maintained in hypoxic
conditions (2 to 3%) before vascularization [42] and in vitro, low
oxygen culture conditions promote maintenance of pluripotency
[5]. Rapid changes in ROS production and oxidative status
associated with vascularization, growth factor binding, or
increased mitochondrial biogenesis and activity, all promote
cellular differentiation and determine cell fate [30].
Our findings highlight the capability of NT-plasma to promote
osteo and chondrogenesis. The mechanism(s) by which both
proliferation and differentiation occur is dependent on both
immediate and long-term signaling molecules. In the short term,
O2
2. and H2O2 are produced during the 10 sec NT-plasma
exposure, however their sustained increases at 1 and 24 hr after
treatment is due to intracellular ROS production. The most likely
sources of the increased intracellular ROS are NADPH oxidase
and mitochondrial production of O2
2., H2O2 and NO
. [42,43].
All three are signaling factors known to participate in cellular
proliferation and differentiation by directly activating ROS or
RNS-responsive proteins or indirectly by altering the redox status
of the cell [44–57]. Specifically, MAP kinases are known to
respond rapidly to ROS stimulation and these kinases control a
wide range of cellular processes including: cellular differentiation,
cell cycle control, cytokine and growth factor signaling, survival,
hypertrophy and/or apoptosis [14–17].
ROS also promote downstream cellular responses by affecting
the activity and expression of specific transcription factors
[24,58,59]. In osteoblast progenitors, continuous production of
low levels of H2O2 stimulates proliferation and augments their
potential to differentiate into mature osteoblasts through up-
regulation of Runx2 and osterix. [22]. In turn, these transcription
factors promote ALKP and osteocalcin expression in differentiat-
ing osteoblasts. Similarly, in the current study, NT-plasma induced
ROS production increased the expression of Runx2, osterix,
ALKP and osteocalcin in pre-osteoblastic MLO-A5 cells.
Conflicting findings have been reported concerning the role of
ROS in cell differentiation, but these discrepancies may be due to
differing methodologies used for the generation of ROS and the
delicate balance required for the appropriate response [57]. In a
recent study comparing glucose oxidase continuous production of
low levels of H2O2 to a single bolus of chemical H2O2, only
glucose oxidase generated H2O2 promoted osteoblast differentia-
tion [22]. This finding is not unexpected as the glucose oxidase
system mimics cellular levels of H2O2 production. In the same
way, a 10 sec exposure to NT-plasma initiates low-level intracel-
lular production of ROS. This emphasizes that both timing and
ROS concentration are critical in directing cell function. In the
same way, chondrocyte differentiation in response to NT-plasma
may be directly linked to ROS induced expression of SOX-9 and
Runx2, which control collagen and aggrecan expression [60]. In a
related study, laser irradiation induced intracellular ROS produc-
tion and enhanced SOX-9 expression leading to chondrocyte
differentiation and expression of collagen and aggrecan [61]. The
roles of ROS in progenitor cell proliferation and differentiation
described above may also be directly applicable to more complex
tissue systems such as regenerating limbs or limb development.
While very little has been reported on the direct contribution of
ROS in the developmental process, it is well established that a
majority of the required signaling molecules (BMPs, WNTs and
FGFs) either directly signal through ROS or are indirectly
controlled by ROS [62–64].
Current studies investigating NT-plasma report multiple effects
can be induced in living cells and tissues [5]: these include
increased cell proliferation [3], enhanced cell transfection [65–67],
selective killing of cancer cells [68] and improved wound healing
[69,70]. The multiple effects can be attributed to the in vitro
conditions selected during cellular treatment with NT-plasma.
Results of the current study highlight the use of NT-plasma as a
tool to initiate a non-lethal oxidative cellular burst that promotes
osteoblast differentiation. Furthermore, these findings suggest that
ROS and RNS produced in response to NT-plasma influence
signaling pathways that are responsible for cellular proliferation
and differentiation. Thus, it would not be unreasonable to assume
that NT-plasma could be used to promote musculoskeletal cell
differentiation and tissue regeneration.
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